Page 5 - Pharma Companies

Pricing trend, launches, stability of growth boosters for Dr Reddy's

Near-term outlook and valuation are expected to support the stock price

Cipla Q3 PAT dips 2.6% at Rs 729 crore

Drug major Cipla on Tuesday reported a 2.6 per cent decline in its consolidated profit after tax to Rs 729 crore for the third quarter ended on December 31, 2021. The Mumbai-based company had posted a consolidated profit after tax (PAT) of Rs 748 crore in the October-December quarter of 2020-21 fiscal. Total revenue from operations, however, rose by 6 per cent to Rs 5,479 crore in the third quarter as compared with Rs 5,169 crore in the same period of last fiscal, Cipla said in a regulatory filing. "I am pleased to see the strong launch and commercial momentum across our core markets during the quarter. Our portfolio execution in branded markets of India and South Africa and strong respiratory traction driving our US generic franchise to a multi-quarter high quarter were key drivers," Cipla MD and Global CEO Umang Vohra noted. The unlocking of the company's first peptide asset, lanreotide injection is an important step in strengthening complex generics engine, inching up the drug .

Omicron spread: Pfizer seeks conditional EU authorisation for Covid-19 pill

The announcement comes as countries in much of the 27-nation bloc are reporting soaring numbers of infections

Brinton Pharma to launch generic version of anti-Covid pill Molnupiravir

The company will introduce it in the domestic market under the brand 'Molviton'

Pharma firm Venus Remedies makes the cut for PLI Scheme

Under this scheme, Venus Remedies will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products

Pharma major Lupin announces launch of its diagnostics business

Homegrown pharma major Lupin Ltd on Friday announced the launch of its diagnostics arm as part of its strategy to provide integrated healthcare in India.

Drug maker Lupin inks pact to distribute, market Pegfilgrastim in Brazil

The company has entered into an exclusive distribution and marketing agreement with Biomm SA in Brazil

Australia's Woolworths makes $613 mln drugstore play, taking on Wesfarmers

The 11th-hour move from Woolworths sets the scene for a bid war between Australia's two largest retail companies

Multiple near-term concerns trigger Divi's Laboratories' headache

Pfizer's oral Covid drug, weak sales of generics, and valuations may cap upsides

Power crisis brewing in China likely to hit Indian pharma companies

Delays in consignments, rising prices of key ingredients worry industry

Germany's Boehringer, Indian pharma in legal battle over diabetes drug

The German drug maker has obtained interim injunctions against MSN Labs and Dr Reddy's Lab

M-cap of 2 demerged entities could exceed Piramal's by 10-15%: Analysts

Analysts say the demerger will make it easier for investors to value the two companies

Zydus Cadila gets USFDA nod to market depression treatment drug in US

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Vortioxetine Tablets, used to treat depression, in the American market.

Glenmark Pharma concludes study on Covid drug Favipiravir in India

Drug firm Glenmark Pharmaceuticals on Wednesday said it has successfully completed its post-marketing surveillance study on Favipiravir in India.

Work on non-Covid vaccines gives pharma firms an injection of hope

Approach drug regulator, seeking permission to conduct clinical trials

Pharma companies lead topline growth in Q1FY22: ICICI Direct Research

Corporate earnings for April-June were robust despite the second wave of Covid-19 and a report by ICICI Direct Research showed that topline growth during quarter was led by pharmaceutical companies

Serum Institute buys 50% stake in pharma packaging firm Schott Kaisha

The joint venture is for pharmaceutical packaging

4 more pharma companies to start vax production by Oct-Nov: Mandaviya

Union Health Minister Mansukh Mandaviya has said that four more Indian pharmaceutical companies may start the vaccine production by October-November to accelerate the inoculation drive.

GlaxoSmithKline Pharma Q1 net profit up 9% at Rs 121 crore

Drug firm GlaxoSmithKline Pharmaceuticals on Monday reported a 9.24 per cent rise in consolidated net profit to Rs 121.08 crore for the quarter ended June 30, 2021.

Vaccine maker BioNTech to use mRNA technology to target malaria

Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.